354 / 460
Patellar tendinosis : Therapeutics options
353
Filardo
et al.
[30] investigated the use of
autologous growth factors through platelet-rich
plasma injections as a treatment of jumper’s
knee: the clinical results were encouraging and
suggested this method could be useful for the
treatment of chronic patellar tendinopathy,
even in difficult recalcitrant to physiotherapy.
Gosens T.
et al.
showed that there may be a
relationship
between
prior
treatments
(ethoxysclerol, steroid or surgery) and the
benefits of PRP. There were no significant
improvement in those who had been treated
before compared to those who only received
PRP [31].
Conclusions
Physical training (particularly eccentric training)
has appeared to be the treatment of choice for
patients suffering from patellar tendinopathy
and remains the standard of care. However,
exercise type, frequency, load and dosage
require further investigations. In cases of failed
non-operative treatment, open or arthroscopic
debridement of the pathologic tissue has shown
improvement in high-level athletes [32].
Ultrasound can be excluded for patellar
tendinopathy treatment and shockwave therapy,
sclerosing injections and PRP require additional
research before their use can be recommended.
Literature
[1] Witvrouw E, Bellemans J, Lysens R
et al.
Intrinsic risk factors for the development of patellar tendinitis
in an athletic population; A two-year prospective study.
Am J
Sports Med 2001; 29: 190-95.
[2] Jarvinen M. Epidemiology of tendon injuries in
sports.
Clin Sports Med 1992; 11:493-504.
[3] Lian OB, Engebretsen L, Bahr R. Prevalence of
jumper’s knee among elite athletes from different sports: A
cross-sectional study.
Am J Sports Med. 2005; 33: 561-7.
[4] Kettunen JA, KujalaUM, Kaprio J. Lower limb
function among former elite male athletes.
Am J Sports Med
2001; 29:2-8.
[5] Khan KM, Cook JL, Bonar F
et al.
Histopathology
of common tendinopathies. Update and implications for
clinical management.
Sports Med. 1999;27: 393-408.
[6] Ljung BO, Forsgren S, Friden J. Substance P and
calcitonin gene-related peptide expression at the extensor
carpi radialis brevis muscle origin: implications for the
etiology of tennis elbow.
J Orthop Res. 1999; 17: 554-9.
[7] Soslowsky LJ, Thomopoulus S, Flanagan
CL
et al.
Neer Award 1999. Overuse activity injures the
supraspinatus tendon in an animal model: a histologic and
biomechanical study.
J Shoulder Elbow Surg. 2000;9: 79-84.
[8] Cook JL, Feller JA, Bonar SF, Khan KM.
Abnormal tenocyte morphology is more prevalent than
collagen disruption in asynptomatic athletes’ patellar
tendons.
J Orthop Res 2004;22: 334-8.
[9] Bahr R, FossanB, Loken S
et al.
Surgical treatment
compared with eccentric training for patellar tendinopathy
(Jumper’s knee). A randomized, controlled trial.
J Bone Joint
Surg [Am] 2006; 88-A: 1689-98.
[10] Jonsson P, Alfredson H. Superior results with
eccentric compared to concentric quadriceps training in
patients with jumper’s knee: a prospective randomized study.
Br J Sports Med 2005; 39: 847-50.
[11] Stasinopoulos D, Stasinopoulos I.
Comparisson of effects of exercise programme, pulsed
ultrasound and transverse friction in the treatment of chronic
patellar tendinopathy.
Clin Reabil 2004; 18(4): 347-52.
[12] Kongsgaard M, Kovanen V, Aagaard P
et
al.
Corticosteroid injections, eccentric decline squat training
and heavy slow resistance training in patellar tendinopathy.
Scand J Med Sci Sports 2009; 19(6): 790-802.
[13] Warden SJ, Metcalf BR, Kiss ZS
et al.
Low-
intensity pulsed ultrasound for chronic patellar tendinopathy:
a randomized, double-blind, placebo-controled trial.
Rheumatology (Oxford) 2008; 47(4): 467-7.
[14] Khanna An Nelmes RT, Gougoulias N
et al.
The effects of LIPUS on soft-tissue healing: a review of
literature.
Br Med Bull 2009; 89: 169-82.
[15] Wang CJ, Ko JY, Chan YS
et al.
Extracorporeal
shockwave for chronic patellar tendinopathy.
Am J Sports
Med 2007; 35(6): 972-8.
[16] Ohberg L, Alfredson H. Ultrasund guided
sclerosis of neovessels in painful chronicAchilles tendinosis:
pilot study of a new treatment.
Br J Sports Med 2002; 36(3):
173-5.
[17] Ohberg L, Alfredson H. Sclerosing therapy in
chronic Achilles tendon insertional pain-results of a pilot
study.
Knee Surg Sports Traumatol Arthrosc 2003; 11(5):
339-43.